Michael Ciraolo
Plus aucun poste en cours
Profil
Michael Ciraolo worked as an Executive Director at Forest Laboratories, Inc. He then worked as an Associate at Baker Botts LLP and ArentFox Schiff LLP.
Later, he worked as the Chief Intellectual Property Counsel & VP at Ovid Therapeutics, Inc. and as the Chief Operating Officer & General Counsel at Neurotrope, Inc. Dr. Ciraolo holds a doctorate degree from Stony Brook University, an undergraduate degree from State University of New York College at Brockport, and a graduate degree from St. John's University School of Law.
Anciens postes connus de Michael Ciraolo
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROTROPE, INC. | Directeur des opérations | 31/10/2019 |
| OVID THERAPEUTICS INC. | Corporate Officer/Principal | 31/03/2019 |
| FOREST LABORATORIES, INC. | Directeur/Membre du Conseil | - |
Baker Botts LLP
 Baker Botts LLP Miscellaneous Commercial ServicesCommercial Services Baker Botts LLP provides legal services. Its services include antitrust and compensation law, corporate, enforcement and investigations, environmental law, intellectual property, litigation, projects, real estate and construction, regulatory, and tax. The firm renders its services to banking and finance industry, energy and natural resources, manufacturing, and technological industries. The company was founded by Peter Gray in 1840 and is headquartered in Houston, Texas. | Corporate Officer/Principal | - |
ArentFox Schiff LLP
 ArentFox Schiff LLP Miscellaneous Commercial ServicesCommercial Services ArentFox Schiff LLP provides legal services. The firm offers their services in areas including the intellectual property, real estate, telecommunications, healthcare, automotive, sports, white collar, international trade, bankruptcy, and complex litigation. The company was founded in 1942 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Formation de Michael Ciraolo
| State University of New York College at Brockport | Undergraduate Degree |
| Stony Brook University | Doctorate Degree |
| St. John's University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OVID THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
ArentFox Schiff LLP
ArentFox Schiff LLP Miscellaneous Commercial ServicesCommercial Services ArentFox Schiff LLP provides legal services. The firm offers their services in areas including the intellectual property, real estate, telecommunications, healthcare, automotive, sports, white collar, international trade, bankruptcy, and complex litigation. The company was founded in 1942 and is headquartered in Washington, DC. | Commercial Services |
Baker Botts LLP
Baker Botts LLP Miscellaneous Commercial ServicesCommercial Services Baker Botts LLP provides legal services. Its services include antitrust and compensation law, corporate, enforcement and investigations, environmental law, intellectual property, litigation, projects, real estate and construction, regulatory, and tax. The firm renders its services to banking and finance industry, energy and natural resources, manufacturing, and technological industries. The company was founded by Peter Gray in 1840 and is headquartered in Houston, Texas. | Commercial Services |
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |